Company has taken up a major expansion plans involving an investment of Rs.75 crores
over a period of next 18 months which includes setting up a R&D center &
Pilot Plant as per the FDA standards . Most of these projects are at an advanced
stage of implementation. In addition the Company's existing facilities are being
upgraded to meet the FDA standards .
To know about our Formulation Division, please visit us at
Ind-Swift Limited, our other group company.